Does furosemide improve renal function in patients stopping renal replacement therapy?

ISRCTN ISRCTN86755640
DOI https://doi.org/10.1186/ISRCTN86755640
Protocol serial number N0060110642
Sponsor Department of Health
Funder Chelsea and Westminster Healthcare NHS Trust (UK)
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
02/02/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Neil Soni
Scientific

Magill Dept of Anaesthetics, 3rd Floor, D Lift
Chelsea & Westminster Hospital
369 Fulham Road
London
SW10 9NH
United Kingdom

Phone +44 (0)20 8237 2763
Email n.soni@imperial.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial parallel design
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleDoes furosemide improve renal function in patients stopping renal replacement therapy?
Study objectivesDoes furosemide improve renal function in patients stopping renal replacement therapy?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedUrological and Genital Diseases: Renal function
InterventionFurosemide vs no furosemide
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Furosemide
Primary outcome measure(s)

Change in creatinine clearance after 24 hours of receiving, or not, furosemide infusion

Key secondary outcome measure(s)

Other outcome measures include rate of resumption of renal replacement therapy, peak creatinine, requirement for mineral replacement

Completion date31/07/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration50
Key inclusion criteria50 patients. 1 per week.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment11/02/2002
Date of final enrolment31/07/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Chelsea & Westminster Hospital
London
SW10 9NH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

02/02/2017: No publications found, verifying study status with principal investigator.